ClinConnect ClinConnect Logo
Search / Trial NCT06780618

The Effects of Brown Rice Compared to White Rice on Postprandial Changes in IL-6 and MDA Levels in Sedentary Workers

Launched by INDONESIA UNIVERSITY · Jan 13, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Brown Rice White Rice Interleukin 6 Malondialdehyde Sedentary Inflammation Oxidative Stress Postprandial

ClinConnect Summary

This clinical trial is looking to understand how eating brown rice compares to white rice in affecting inflammation and oxidative stress in office workers who do not exercise much. Specifically, the researchers want to see if these two types of rice influence levels of certain substances in the blood that are related to inflammation and stress in the body after a meal.

To participate, you need to be a healthy office worker between the ages of 21 and 59, with a normal body weight and low physical activity. If you join, you will be interviewed about your health and lifestyle, measured for your body mass index (BMI), and asked to keep track of what you eat for a day. You will then eat a meal that includes either brown or white rice, and your blood will be taken before and after the meal to see how it affects your body. This study is important because it can help us understand how different types of rice may impact health, especially for people with sedentary lifestyles.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • healthy administrative employees,
  • age 21-59 years,
  • normal body mass index (18.5-22.9 kg/m2),
  • low physical activity (≤600 METs minutes/week),
  • assign for informed consent
  • Exclusion Criteria:
  • being pregnant/breastfed/menopause,
  • consumption of herbal medicines and/or supplements within 24 hours before data collection,
  • having history of DM, CVD, cancer, and autoimmune disease,
  • being vegan,
  • smoking/alcohol drinking,
  • allergic to research food's ingredients

About Indonesia University

Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.

Locations

Jakarta, , Indonesia

Patients applied

0 patients applied

Trial Officials

Wulandari Taradita, MD

Principal Investigator

Department of Nutrition Faculty of Medicine University of Indonesia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported